Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Confronting obesity in the Middle East: Cultural, social and policy challenges

This report is based on five in-depth interviews with senior obesity experts from the region, complemented by extensive desk research. The main findings of the research are as follows: 

Fighting cancer with artificial intelligence

AI systems are already being used both to diagnose cancer and to develop new treatments

Reducing the burden: The economic and social costs of lung cancer in Italy

Reducing the burden: The economic and social costs of lung cancer in Italy presents the results of this research. This white paper was written by The Economist Intelligence Unit (EIU) and sponsored by Roche. It is based on desk research and in-depth interviews with 15 experts in the topic.

Reducing the burden: The economic and social costs of lung cancer in Italy

The incidence of lung cancer is rising in Italy, particularly among women. On the other hand Italy, like many of its European neighbours, is improving the ways that it fights lung cancern, both in a clinical sense and through an array of broader policies. By considering a variety of measures to discourage smoking, and by experimenting with innovative approaches to financing new treatments, Italy is starting to formulate plans to reduce the burdens of the disease.

Tackling tuberculosis in South Africa: Building on the political momentum

As a relatively wealthy African country and one of the BRICS nations (Brazil, Russia, India, China and South Africa), South Africa has been able to make more substantial investments in combating tuberculosis (TB) and multi-drug-resistant tuberculosis (MDR TB) than many others in the region. This, combined with strong political will, has put South Africa ahead of many of its peers in the fight against the disease.

 

Tackling tuberculosis in Nigeria: Funding gaps and fragmentation

For Nigeria, the barriers to tackling multidrug-resistant tuberculosis (MDR TB) include external factors such as the Boko Haram insurgency (which is also hampering the battle against polio). However, persistent weaknesses in the country’s health system that are lowering its diagnosis and treatment capacity are also contributing to Nigeria’s struggle to control tuberculosis (TB) and MDR TB.

 

Tackling tuberculosis in Kenya: A decentralised approach to care

With the help of international funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development (USAID) and others, Kenya is planning to scale up its response to tuberculosis (TB) and multidrug-resistant tuberculosis (MDR TB) by 2017. But although the political will to fight the disease is there, experts and policymakers recognise that MDR TB cannot be tackled in isolation.

 

Tackling tuberculosis in Ethiopia: A community-based approach

Although Ethiopia has only limited resources to spend on combating tuberculosis (TB) and multidrug-resistant tuberculosis (MDR TB), its innovative, community-based approach demonstrates that a poor country which lacks sophisticated healthcare systems and medical specialists can nevertheless respond aggressively in the battle against TB and MDR TB.

 

Tackling tuberculosis: Recent progress and challenges

Tackling tuberculosis: Recent progress and challenges

Although TB was responsible for around 1.5m deaths in 2014, down from nearly 1.8m in 1990, it is now the leading infectious disease killer worldwide, surpassing HIV/AIDS.[1] According to Mario Raviglione, director of the Global TB Programme at the World Health Organisation (WHO), incidence of the disease has been falling by around 1.5% annually for around a decade, but meeting the WHO’s goal of reducing TB by 90% by 2030 would require a reduction in incidence of 10% per year over the next decade—a goal that looks increasingly preca

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week